Skip to main content

Advertisement

SpringerLink
Log in

Tocolysis for preterm labor: Expert opinion

  • Position Statements and Guidelines
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Tocolysis is an important treatment in the improvement of outcome in preterm labor and preterm birth, provided that its use follows clear evidence-based recommendations. In this expert opinion, the most recent evidence about efficacy and side effects of different tocolytics is being reviewed and evidence-based recommendation about diagnosis and treatment of preterm labor is given. Further aspects such as progesterone administration or antibiotic treatment for the prevention of preterm birth are included. Our review demonstrates that an individualized choice of different tocolytics and additional treatments is necessary to improve short- and long-term neonatal outcome in preterm labor and preterm birth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bundesamt für Statistik aktuell (2010) Gesundheit der Neugeborenen 2008 Frühgeburten, Mehrlingsschwangerschaften und Wachstumsretardierung. wwwadminch

  2. McCormick MC (1985) The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 312(2):82–90. doi:10.1056/NEJM198501103120204

    Article  CAS  PubMed  Google Scholar 

  3. Ness A, Visintine J, Ricci E, Berghella V (2007) Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial. Am J Obstet Gynecol 197(4):426 e1–426 e7. doi:S0002-9378(07)00884-8

    Article  Google Scholar 

  4. Surbek D, D G, Irion O, Nelle M, Hösli I (2009) Lungenreifungsinduktion bei drohender Frühgeburt: Standardindikationen und Dosierung. SGGG Expertenbrief No 34

  5. Goffinet F (2005) Primary predictors of preterm labour. BJOG 112(Suppl 1):38–47. doi:10.1111/j.1471-0528.2005.00583.x

    Article  PubMed  Google Scholar 

  6. Moreau C, Kaminski M, Ancel PY, Bouyer J, Escande B, Thiriez G et al (2005) Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study. BJOG 112(4):430–437. doi:10.1111/j.1471-0528.2004.00478.x

    Article  PubMed  Google Scholar 

  7. Gomez R, Galasso M, Romero R, Mazor M, Sorokin Y, Goncalves L et al (1994) Ultrasonographic examination of the uterine cervix is better than cervical digital examination as a predictor of the likelihood of premature delivery in patients with preterm labor and intact membranes. Am J Obstet Gynecol 171(4):956–964. doi:0002-9378(94)90014-0

    Article  CAS  PubMed  Google Scholar 

  8. Crane JM, Van den Hof M, Armson BA, Liston R (1997) Transvaginal ultrasound in the prediction of preterm delivery: singleton and twin gestations. Obstet Gynecol 90(3):357–363. doi:S0029-7844(97)00277-9

    Article  CAS  PubMed  Google Scholar 

  9. Sonek JD, Iams JD, Blumenfeld M, Johnson F, Landon M, Gabbe S (1990) Measurement of cervical length in pregnancy: comparison between vaginal ultrasonography and digital examination. Obstet Gynecol 76(2):172–175

    CAS  PubMed  Google Scholar 

  10. Schutte MF, Treffers PE, Kloosterman GJ, Soepatmi S (1983) Management of premature rupture of membranes: the risk of vaginal examination to the infant. Am J Obstet Gynecol 146(4):395–400

    CAS  PubMed  Google Scholar 

  11. Munson LA, Graham A, Koos BJ, Valenzuela GJ (1985) Is there a need for digital examination in patients with spontaneous rupture of the membranes? Am J Obstet Gynecol 153(5):562–563. doi:0002-9378(85)90474-0

    Article  CAS  PubMed  Google Scholar 

  12. Birkenmaier A, Ries JJ, Kuhle J, Burki N, Lapaire O, Hosli I (2012) Placental alpha-microglobulin-1 to detect uncertain rupture of membranes in a European cohort of pregnancies. Arch Gynecol Obstet. doi:10.1007/s00404-011-1895-9

    PubMed  Google Scholar 

  13. Hassan SS, Romero R, Berry SM, Dang K, Blackwell SC, Treadwell MC et al (2000) Patients with an ultrasonographic cervical length < or = 15 mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol 182(6):1458–1467. doi:S0002-9378(00)81396-4

    Article  CAS  PubMed  Google Scholar 

  14. ACOG Practice Bulletin (2001) Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician–gynecologists. Number 31, October 2001. (Replaces Technical Bulletin number 206, June 1995; Committee Opinion number 172, May 1996; Committee Opinion number 187, September 1997; Committee Opinion number 198, February 1998; and Committee Opinion number 251, January 2001). Obstet Gynecol 98(4):709–716

    Google Scholar 

  15. Kagan KO, To M, Tsoi E, Nicolaides KH (2006) Preterm birth: the value of sonographic measurement of cervical length. BJOG 113(Suppl 3):52–56. doi:10.1111/j.1471-0528.2006.01124.x

    Article  PubMed  Google Scholar 

  16. Chandiramani M, Di Renzo GC, Gottschalk E, Helmer H, Henrich W, Hoesli I et al (2011) Fetal fibronectin as a predictor of spontaneous preterm birth: a European perspective. J Matern Fetal Neonatal Med 24(2):330–336. doi:10.3109/14767058.2010.496879

    Article  PubMed  Google Scholar 

  17. Crowley P (2000) Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev (2):CD000065. 10.1002/14651858.CD000065

  18. American College of O, Gynecologists, Committee on Practice B-O (2012) ACOG practice bulletin no. 127: management of preterm labor. Obstet Gynecol 119(6):1308–1317. doi:10.1097/AOG.0b013e31825af2f0

    Article  Google Scholar 

  19. Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A (1999) Tocolytics for preterm labor: a systematic review. Obstet Gynecol 94(5 Pt 2):869–877

    Article  CAS  PubMed  Google Scholar 

  20. RCOG (2011) Tocolysis for women in preterm labour guidelines for the management of spontaneous preterm labour Green top clinical guideline No 1(B)

  21. Conde-Agudelo A, Romero R, Kusanovic JP (2011) Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol 204(2):134 e1–134 e20. doi:10.1016/j.ajog.2010.11.038

    Article  Google Scholar 

  22. DGGG (2010) Leitlinien Medikamentöse Wehenhemmung bei drohender Frühgeburt

  23. de Heus R, Mol BW, Erwich JJ, van Geijn HP, Gyselaers WJ, Hanssens M et al (2009) Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ 338:b744

    Article  PubMed Central  PubMed  Google Scholar 

  24. Herzog S, Cunze T, Martin M, Osmers R, Gleiter C, Kuhn W (1999) Pulsatile vs. continuous parenteral tocolysis: comparison of side effects. Eur J Obstet Gynecol Reprod Biol 85(2):199–204. doi:S0301211599000305

    Article  CAS  PubMed  Google Scholar 

  25. Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S (2004) Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. (4):CD004352. doi: 10.1002/14651858.CD004352.pub2

  26. The Worldwide Atosiban versus Beta-agonists Study Group (2001) Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG 108(2):133–142

    Article  Google Scholar 

  27. Coomarasamy A, Knox EM, Gee H, Khan KS (2002) Oxytocin antagonists for tocolysis in preterm labour–a systematic review. Med Sci Monit 8(11):RA268–RA273

    CAS  PubMed  Google Scholar 

  28. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B et al (2000) An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 182(5):1173–1183

    Article  CAS  PubMed  Google Scholar 

  29. Di Renzo GC, Roura LC (2006) Guidelines for the management of spontaneous preterm labor. J Perinat Med 34(5):359–366. doi:10.1515/JPM.2006.073

    Article  PubMed  Google Scholar 

  30. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B (2001) Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol 97(5 Pt 2):840–847. doi:S0029784400012126

    Article  CAS  PubMed  Google Scholar 

  31. King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B (2003) Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev. (1):CD002255. doi: 10.1002/14651858.CD002255

  32. Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ (2012) Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 345:e6226

    Article  PubMed  Google Scholar 

  33. Papatsonis DN, Van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA (1997) Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 90(2):230–234. doi:10.1016/S0029-7844(97)00182-8

    Article  CAS  PubMed  Google Scholar 

  34. Zimmermann R (2012) Handbuch Geburtshilfe

  35. Silberschmidt AL, Kuhn-Velten WN, Juon AM, Zimmermann R, von Mandach U (2008) Nifedipine concentration in maternal and umbilical cord blood after nifedipine gastrointestinal therapeutic system for tocolysis. BJOG 115(4):480–485. doi:10.1111/j.1471-0528.2007.01630.x

    Article  PubMed  Google Scholar 

  36. Juon AM, Kuhn-Velten WN, Burkhardt T, Krahenmann F, Zimmermann R, von Mandach U (2008) Nifedipine gastrointestinal therapeutic system (GITS) as an alternative to slow-release for tocolysis–tolerance and pharmacokinetic profile. Eur J Obstet Gynecol Reprod Biol 140(1):27–32. doi:10.1016/j.ejogrb.2008.02.003

    Article  CAS  PubMed  Google Scholar 

  37. Magee LA, Miremadi S, Li J, Cheng C, Ensom MH, Carleton B et al (2005) Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 193(1):153–163. doi:10.1016/j.ajog.2004.11.059

    Article  CAS  PubMed  Google Scholar 

  38. sapp.info (2010) Monographie Nifedipin. www sappinfo Monographie Nifedipin

  39. Haas DM, Imperiale TF, Kirkpatrick PR, Klein RW, Zollinger TW, Golichowski AM (2009) Tocolytic therapy: a meta-analysis and decision analysis. Obstet Gynecol 113(3):585–594. doi:10.1097/AOG.0b013e318199924a

    Article  PubMed  Google Scholar 

  40. King J, Flenady V, Cole S, Thornton S (2005) Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev (2):CD001992. doi:10.1002/14651858.CD001992.pub2

  41. Smith GN, Walker MC, Ohlsson A, O’Brien K, Windrim R (2007) Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor. Am J Obstet Gynecol 196(1):37 e1–37.e8. doi:10.1016/j.ajog.2006.10.868

    Article  Google Scholar 

  42. Crowther CA, Hiller JE, Doyle LW (2002) Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev (4):CD001060. doi: 10.1002/14651858.CD001060

  43. Grimes DA, Nanda K (2006) Magnesium sulfate tocolysis: time to quit. Obstet Gynecol 108(4):986–989. doi:10.1097/01.AOG.0000236445.18265.93

    Article  CAS  PubMed  Google Scholar 

  44. Jeyabalan A, Caritis SN (2002) Pharmacologic inhibition of preterm labor. Clin Obstet Gynecol 45(1):99–113

    Article  PubMed  Google Scholar 

  45. Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM et al (2008) A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 359(9):895–905. doi:10.1056/NEJMoa0801187

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. SGGG (2007) Expertenbrief No. 23 “Off Label Use” von Arzneimitteln in der Gynäkologie und Geburtshilfe

  47. Lyell DJ, Pullen KM, Mannan J, Chitkara U, Druzin ML, Caughey AB et al (2008) Maintenance nifedipine tocolysis compared with placebo: a randomized controlled trial. Obstet Gynecol 112(6):1221–1226. doi:10.1097/AOG.0b013e31818d8386

    Article  CAS  PubMed  Google Scholar 

  48. Dodd JM, Crowther CA, Dare MR, Middleton P (2006) Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database Syst Rev (1):CD003927. doi: 10.1002/14651858.CD003927.pub2

  49. Whitworth M, Quenby S (2008) Prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies. Cochrane Database Syst Rev (1):CD006395. doi: 10.1002/14651858.CD006395.pub2

  50. Papatsonis D, Flenady V, Liley H (2009) Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour. Cochrane Database Syst Rev (1):CD005938. doi: 10.1002/14651858.CD005938.pub2

  51. Sosa C, Althabe F, Belizan J, Bergel E (2004) Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev (1):CD003581. doi: 10.1002/14651858.CD003581.pub2

  52. Heaman M, Gupton A (1998) Perceptions of bed rest by women with high-risk pregnancies: a comparison between home and hospital. Birth 25(4):252–258

    Article  CAS  PubMed  Google Scholar 

  53. Heaman MI, Blanchard JF, Gupton AL, Moffatt ME, Currie RF (2005) Risk factors for spontaneous preterm birth among Aboriginal and non-Aboriginal women in Manitoba. Paediatr Perinat Epidemiol 19(3):181–193. doi:10.1111/j.1365-3016.2005.00644.x

    Article  PubMed  Google Scholar 

  54. Wachter R, Brenneisen R, Hamburger M, Mennet M, Schnelle M, Worel AM et al (2011) Leaf press juice from Bryophyllum pinnatum (Lamarck) Oken induces myometrial relaxation. Phytomedicine. doi:10.1016/j.phymed.2011.06.032

    PubMed  Google Scholar 

  55. Plangger N, Rist L, Zimmermann R, von Mandach U (2006) Intravenous tocolysis with Bryophyllum pinnatum is better tolerated than beta-agonist application. Eur J Obstet Gynecol Reprod Biol 124(2):168–172. doi:10.1016/j.ejogrb.2005.05.013

    Article  CAS  PubMed  Google Scholar 

  56. Gwehenberger B, Rist L, Huch R, von Mandach U (2004) Effect of Bryophyllum pinnatum versus fenoterol on uterine contractility. Eur J Obstet Gynecol Reprod Biol 113(2):164–171. doi:10.1016/S0301-2115(03)00370-1

    Article  PubMed  Google Scholar 

  57. King J, Flenady V (2002) Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev (4):CD000246. doi: 10.1002/14651858.CD000246

  58. Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A et al (2008) Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 372(9646):1319–1327. doi:10.1016/S0140-6736(08)

    Article  CAS  PubMed  Google Scholar 

  59. Verani JR, McGee L, Schrag SJ (2010) Prevention of perinatal group B streptococcal disease—revised guidelines from CDC. MMWR Recomm Rep 59(RR-10):1–36

    PubMed  Google Scholar 

  60. Kenyon SL, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group (2001) Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 357(9261):979–988. doi:S0140673600042331

    Article  CAS  PubMed  Google Scholar 

  61. Dodd JM, Flenady V, Cincotta R, Crowther CA (2006) Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev (1):CD004947. doi: 10.1002/14651858.CD004947.pub2

  62. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M et al (2011) Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 38(1):18–31. doi:10.1002/uog.9017

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  63. Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O’Brien JM, Cetingoz E et al (2012) Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 206(2):124 e1–124 e19. doi:10.1016/j.ajog.2011.12.003

    Article  Google Scholar 

  64. Meis PJ, Aleman A (2004) Progesterone treatment to prevent preterm birth. Drugs 64(21):2463–2474

    Article  CAS  PubMed  Google Scholar 

  65. Sanchez-Ramos L, Kaunitz AM, Delke I (2005) Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Obstet Gynecol 105(2):273–279. doi:10.1097/01.AOG.0000150559.59531.b2

    Article  CAS  PubMed  Google Scholar 

  66. Likis FE, Edwards DR, Andrews JC, Woodworth AL, Jerome RN, Fonnesbeck CJ et al (2012) Progestogens for preterm birth prevention: a systematic review and meta-analysis. Obstet Gynecol 120(4):897–907. doi:10.1097/AOG.0b013e3182699a15

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors report no conflict of interest.

Author information

Authors and Affiliations

  1. Committee for Quality Assurance, Swiss Society of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, University Hospital Inselspital, Effingerstrasse 102, 3010, Bern, Switzerland

    Irène Hösli, Christiane Sperschneider, Gero Drack, Roland Zimmermann, Daniel Surbek & Olivier Irion

Authors
  1. Irène Hösli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christiane Sperschneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gero Drack
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roland Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel Surbek
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Olivier Irion
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Surbek.

Additional information

Committee for Quality Assurance of the Swiss Society of Obstetrics and Gynecology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hösli, I., Sperschneider, C., Drack, G. et al. Tocolysis for preterm labor: Expert opinion. Arch Gynecol Obstet 289, 903–909 (2014). https://doi.org/10.1007/s00404-013-3137-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-013-3137-9

Keywords

Search

Navigation